Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wyeth is now a wholly owned subsidiary of Pfizer
Age
6–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 6 years
Male previously treated patients (≥150 Exposure Days) with moderate or severe hemophilia A (i.e. ≤ 5% FVIII:C) who will undergo elective major surgery that is anticipated to require at least 6 consecutive days of daily factor VIII (FVIII) infusions (surgical and post-surgical prophylaxis)
Ability to adhere to the protocol requirements
You may not be if
Hypersensitivity to ReFacto, murine allergen, or hamster allergen 2 History of FVIII inhibitor or current inhibitor, defined as \> 0.6 BU
Prior participation in this study
Any concomitant bleeding disorder other than hemophilia A
Clareo Health | Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery
